Quadrant Capital Group LLC
- SEC CIK
- 0001650717
- Latest filing
- Aug 14, 2026
ABUS holding history
Arbutus Biopharma Corp in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABUS overviewAll 13F holders of ABUSFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −277−100.0% | Sold out | Holders |
| Q1 2026 | 277 | $1.25K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 277 | $1.33K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 277 | $1.26K | <0.1% | +277 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −878−100.0% | Sold out | Holders |
| Q1 2025 | 878 | $3.06K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 878 | $2.87K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 878 | $3.38K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 878 | $2.71K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 878 | $2.27K | <0.1% | +601+217.0% | Added | Holders |
| Q4 2023 | 277 | $693 | <0.1% | −635−69.6% | Reduced | Holders |
| Q3 2023 | 912 | $1.85K | <0.1% | +912 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −205−100.0% | Sold out | Holders |
| Q1 2023 | 205 | $622 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 205 | $478 | <0.1% | −5,196−96.2% | Reduced | Holders |
| Q3 2022 | 5,401 | $10.0K | <0.1% | +5,401 | New | Holders |